Guenther S - Search Results

1

The JAVELIN Bladder Medley trial: avelumab-based combinations as first-line maintenance in advanced urothelial carcinoma.

Hoffman-Censits J, Grivas P, Powles T, Hawley J, Tyroller K, Seeberger S, Guenther S, Jacob N, Mehr KT, Hahn NM. Hoffman-Censits J, et al. Among authors: guenther s. Future Oncol. 2024 Feb;20(4):179-190. doi: 10.2217/fon-2023-0492. Epub 2023 Sep 6. Future Oncol. 2024. PMID: 37671748 Free article.

2

Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current State.

Grivas P, Monk BJ, Petrylak D, Reck M, Foley G, Guenther S, Hennessy D, Makris C, Moehler M. Grivas P, et al. Among authors: guenther s. Target Oncol. 2019 Oct;14(5):505-525. doi: 10.1007/s11523-019-00665-1. Target Oncol. 2019. PMID: 31535338 Review.

3

Avelumab first-line maintenance treatment for advanced urothelial carcinoma: review of evidence to guide clinical practice.

Grivas P, Grande E, Davis ID, Moon HH, Grimm MO, Gupta S, Barthélémy P, Thibault C, Guenther S, Hanson S, Sternberg CN. Grivas P, et al. Among authors: guenther s. ESMO Open. 2023 Dec;8(6):102050. doi: 10.1016/j.esmoop.2023.102050. Epub 2023 Oct 12. ESMO Open. 2023. PMID: 37976999 Free PMC article. Review.

4

Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis.

Niegisch G, Grimm MO, Hardtstock F, Krieger J, Starry A, Osowski U, Guenther S, Deiters B, Maywald U, Wilke T, Kearney M. Niegisch G, et al. Among authors: guenther s. Future Oncol. 2024;20(19):1351-1366. doi: 10.2217/fon-2023-1065. Epub 2024 Apr 22. Future Oncol. 2024. PMID: 38647011 Free PMC article.

5

Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial.

Vaishampayan U, Schöffski P, Ravaud A, Borel C, Peguero J, Chaves J, Morris JC, Kotecki N, Smakal M, Zhou D, Guenther S, Bajars M, Gulley JL. Vaishampayan U, et al. Among authors: guenther s. J Immunother Cancer. 2019 Oct 24;7(1):275. doi: 10.1186/s40425-019-0746-2. J Immunother Cancer. 2019. PMID: 31651359 Free PMC article. Clinical Trial.

6

Split-Dose Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Literature Review and Network Meta-Analysis.

O'Dwyer R, Musat MG, Gulas I, Hubscher E, Moradian H, Guenther S, Kearney M, Sridhar SS. O'Dwyer R, et al. Among authors: guenther s. Clin Genitourin Cancer. 2024 Dec;22(6):102176. doi: 10.1016/j.clgc.2024.102176. Epub 2024 Jul 25. Clin Genitourin Cancer. 2024. PMID: 39260094 Free article.

7

Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives.

Taieb J, Moehler M, Boku N, Ajani JA, Yañez Ruiz E, Ryu MH, Guenther S, Chand V, Bang YJ. Taieb J, et al. Among authors: guenther s. Cancer Treat Rev. 2018 May;66:104-113. doi: 10.1016/j.ctrv.2018.04.004. Epub 2018 Apr 22. Cancer Treat Rev. 2018. PMID: 29730461 Free article. Review.

8

Quality of Life Analysis in Patients With RAS Wild-Type Metastatic Colorectal Cancer Treated With First-Line Cetuximab Plus Chemotherapy.

Yamaguchi K, Ando M, Ooki A, Beier F, Guenther S, von Hohnhorst P, Van Cutsem E. Yamaguchi K, et al. Among authors: guenther s. Clin Colorectal Cancer. 2017 Jun;16(2):e29-e37. doi: 10.1016/j.clcc.2016.07.017. Epub 2016 Aug 9. Clin Colorectal Cancer. 2017. PMID: 28081962 Free article.

9

Electroencephalography in emerging viral infections: Lessons learned from implementing an EEG unit in a Lassa fever isolation ward in Nigeria.

Mueller HCS, Erameh CO, Gelderblom M, Edeawe OI, Akpasubi OG, Ekoyata EU, Aiterebhe UM, Okoeguale J, Guenther S, Oestereich L, Ramharter M, Okogbenin S, Omansen T. Mueller HCS, et al. Among authors: guenther s. PLoS Negl Trop Dis. 2024 Oct 2;18(10):e0012522. doi: 10.1371/journal.pntd.0012522. eCollection 2024 Oct. PLoS Negl Trop Dis. 2024. PMID: 39356691 Free PMC article.

10

Temporary mechanical circulatory support in infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials with 6-month follow-up.

Thiele H, Møller JE, Henriques JPS, Bogerd M, Seyfarth M, Burkhoff D, Ostadal P, Rokyta R, Belohlavek J, Massberg S, Flather M, Hochadel M, Schneider S, Desch S, Freund A, Eiskjær H, Mangner N, Pöss J, Polzin A, Schulze PC, Skurk C, Zeymer U, Hassager C; MCS Collaborator Scientific Group. Thiele H, et al. Lancet. 2024 Sep 14;404(10457):1019-1028. doi: 10.1016/S0140-6736(24)01448-X. Epub 2024 Sep 2. Lancet. 2024. PMID: 39236726

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters